Deutsche Bank Ag\ Cytosorbents Corp Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.76 - $3.22 $11,186 - $20,466	-6,356 Reduced 26.44%	17,681 $39,000
Q1 2022 May 13, 2022	SELL	$2.88 - $4.23 $28,967 - $42,545	-10,058 Reduced 29.5%	24,037 $76,000
Q4 2021 Feb 11, 2022	BUY	$4.05 - $8.11 $5,370 - $10,753	1,326 Added 4.05%	34,095 $143,000
Q3 2021 Nov 04, 2021	SELL	$7.0 - $9.71 $12,523 - $17,371	-1,789 Reduced 5.18%	32,769 $266,000
Q2 2021 Aug 11, 2021	SELL	$7.55 - $9.42 $6,160 - $7,686	-816 Reduced 2.31%	34,558 $261,000
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $20,542 - $28,654	-2,496 Reduced 6.59%	35,374 $307,000
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $61,146 - $71,777	7,993 Added 26.75%	37,870 $302,000
Q3 2020 Nov 12, 2020	SELL	$7.37 - $11.54 $336,212 - $526,443	-45,619 Reduced 60.43%	29,877 $238,000
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $362,550 - $611,371	57,731 Added 324.97%	75,496 $748,000
Q1 2020 May 14, 2020	SELL	$3.77 - $7.73 $2,329 - $4,777	-618 Reduced 3.36%	17,765 $138,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $34,284 - $49,574	9,497 Added 106.88%	18,383 $70,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $65,166 - $114,831	-15,050 Reduced 62.88%	8,886 $43,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $310,486 - $408,037	-52,447 Reduced 68.66%	23,936 $157,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $573,991 - $720,435	-84,163 Reduced 52.42%	76,383 $577,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $654,818 - $1.17 Million	92,882 Added 137.27%	160,546 $1.3 Million
Q3 2018 Dec 21, 2021	BUY	$10.95 - $14.8 $85,793 - $115,958	7,835 Added 13.1%	67,664 $872,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $208,531 - $281,851	-19,044 Reduced 24.15%	59,829 $771,000
Q2 2018 Apr 21, 2020	BUY	$6.9 - $12.35 $63,583 - $113,805	9,215 Added 13.23%	78,873 $900,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $12.35 $55,517 - $99,368	-8,046 Reduced 10.35%	69,658 $792,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $508,961 - $637,172	77,704 New	77,704 $547,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.92 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.75 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.52 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.57 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$2.03 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $57.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account